Compound Summary
L-threonine
Compound Information
L-threonine
Compound Name: | L-threonine |
Compound CID: | 6288 |
Synonyms: | L-threonine threonine 72-19-5 L-(-)-Threonine Threonin More... |
Iupac Name: | (2S,3R)-2-amino-3-hydroxybutanoic acid |
InChI: | InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1 |
InChIKey: | AYFVYJQAPQTCCC-GBXIJSLDSA-N |
Canonical Smiles: | CC(C(C(=O)O)N)O |
Isomeric Smiles: | C[C@H]([C@@H](C(=O)O)N)O |
Molecular Weight: | 119.12 |
Molecular Formula: | C4H9NO3 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
L-threonine
Molecular Weight: | 119.12 |
Molecular Formula: | C4H9NO3 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 2 |
Heavy Atom Count: | 8 |
Complexity: | 93.3 |
Synonyms
L-threonine
| L-threonine | L-threonine |
|---|---|
L-threonine |
threonine |
72-19-5 |
L-(-)-Threonine |
Threonin |
(2S,3R)-2-amino-3-hydroxybutanoic acid |
(S)-Threonine |
H-Thr-OH |
2-amino-3-hydroxybutyric acid |
Threonine (VAN) |
Threoninum Latin |
Treonina Spanish |
(2S,3R)-2-Amino-3-hydroxybutyric acid |
Threonine USAN:INN |
Threonine, L- |
thre |
L-Threonin |
L-thr |
(2S)-threonine |
L-alpha-Amino-beta-hydroxybutyric acid |
(2S,3R)-(-)-Threonine |
2-Amino-3-hydroxybutanoic acid, (R-(R*,S*))- |
UNII-2ZD004190S |
Butanoic acid, 2-amino-3-hydroxy-, (R-(R*,S*))- |
L-2-Amino-3-hydroxybutyric acid |
MFCD00064270 |
CHEBI:16857 |
R-(R*,S*)-2-Amino-3-hydroxybutanoic acid |
2ZD004190S |
THREONINE (L) |
6028-28-0 |
(2S,3R)-rel-2-Amino-3-hydroxybutanoic acid |
DSSTox_CID_26412 |
DSSTox_RID_81591 |
DSSTox_GSID_46412 |
DL-allothreonine |
Threonine # |
Threoninum |
Treonina |
thr |
Threonine, DL- |
Allothreonine, D- |
CAS-72-19-5 |
(R-(R*,S*))-2-Amino-3-hydroxybutanoate |
R-(R*,S*)-2-Amino-3-hydroxybutanoate |
(R-(R*,S*))-2-Amino-3-hydroxybutanoic acid |
L-(U-14C)Threonine |
EINECS 200-774-1 |
NSC 16589 |
NSC 46701 |
NSC46701 |
MFCD00063722 |
HSDB 7797 |
L-Threonine; |
(+/-)-2-Amino-3-hydroxybutyric acid |
NCGC00164520-01 |
NCGC00164520-02 |
Threonine (USP) |
L-Threonine,(S) |
L-Thr-OH |
L-Threonine (9CI) |
Threonine, labeled with carbon-14, L- |
L-Threonine (JP17) |
Threonine, L- (8CI) |
2-Amino-3-hydroxybutyrate |
bmse000049 |
bmse000810 |
bmse000859 |
L-Threonine (H-Thr-OH) |
2-Amino-3-hydroxybutanoate |
SCHEMBL1480 |
L-2-Amino-3-hydroxybutyrate |
L-Threonine non-animal source |
CCRIS 8603 |
CHEMBL291747 |
GTPL4785 |
DTXSID2046412 |
DTXSID70893087 |
DTXSID301015364 |
L-alpha-Amino-beta-hydroxybutyrate |
L-Threonine, Cell Culture Reagent |
Pharmakon1600-01301008 |
ZINC895103 |
HY-N0658 |
EINECS 201-300-6 |
Tox21_112154 |
AC7878 |
NSC760118 |
s4951 |
(2S,3R)-2-Amino-3-hydroxybutyrate |
AKOS006240505 |
AKOS015840277 |
Tox21_112154_1 |
CCG-214540 |
CS-W020046 |
DB00156 |
MCULE-5505393195 |
NSC 206292 |
NSC-760118 |
7013-32-3 |
AC-11296 |
AS-12789 |
L-Threonine, BioXtra, >=99.5% (NT) |
L-Threonine, p.a., 99.0-101.0% |
AI3-18477 |
DB-029984 |
R-(R*,S*)-2-amino-3-hydroxy-Butanoate |
AM20100684 |
T0230 |
L-Threonine, reagent grade, >=98% (HPLC) |
72T195 |
C00188 |
D00041 |
M02962 |
R-(R*,S*)-2-amino-3-hydroxy-Butanoic acid |
88847-EP2289892A1 |
88847-EP2305825A1 |
L-Threonine, Vetec(TM) reagent grade, >=98% |
Q186521 |
3DD2E9AD-DB9A-460E-8A6B-C01B0F67AC4E |
Q-201331 |
48: PN: WO2004076659 FIGURE: 7 claimed sequence |
F8881-8883 |
L-Threonine, certified reference material, TraceCERT(R) |
Z1259341114 |
L-Threonine, European Pharmacopoeia (EP) Reference Standard |
UNII-0O72R8RF8A component AYFVYJQAPQTCCC-GBXIJSLDSA-N |
UNII-N7U7BXP2OI component AYFVYJQAPQTCCC-GBXIJSLDSA-N |
UNII-TFM6DU5S6A component AYFVYJQAPQTCCC-GBXIJSLDSA-N |
L-Threonine, United States Pharmacopeia (USP) Reference Standard |
L-Threonine, Pharmaceutical Secondary Standard; Certified Reference Material |
L-Threonine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0% |
L-Threonine, PharmaGrade, Ajinomoto, EP, JP, USP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture |
Experimental Data
L-threonine
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 1.000000000000000 | mM | 0.000000000000000 | NS | N2 | 25643626 | Inactive | ||||||
| Caenorhabditis elegans | 5.000000000000000 | mM | 3.000000000000000 | NS | N2 | 25643626 | Inactive | ||||||
| Caenorhabditis elegans | 10.000000000000000 | mM | 8.000000000000000 | S | N2 | 25643626 | Active |
Experimental Data Visualization
L-threonine
Statistics Data
L-threonine
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 8.000000000000000 | 1 | 3 |
Statistics Data Visualization
L-threonine
